Cardiac Safety Research Consortium: Can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward
Darpo B, et al. Cardiac Safety Research Consortium: Can the thorough QT/QTc study be replaced by early QT assessment in routine clinical pharmacology studies? Scientific update and a research proposal for a path forward. Am Heart J. 2014; 168(3): 262-272
Related
This entry was posted in QT Proarrhythmia. Bookmark the permalink.
Post navigation
← Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: A report from the Cardiac Safety Research Consortium
Novel oral anticoagulants and reversal agents: Considerations for clinical development →
UPCOMING EVENTS
POSTPONED: CSRC Re-Launch Annual Meeting
ONGOING: TECHNICAL SPECIFICATION FOR SUBMITTING DATA FAR QT STUDIES
Related
NEWS & UPDATES
CSRC and ACCP Sign Collaborative Memorandum of Understading
Through the partnership, CSRC and ACCP will develop, plan, and conduct various educational events and programs and produce research and policy statements/position papers regarding clinical pharmacology and cardiac and vascular safety of medical products.
Related
CURRENT PROJECTS
- CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study
The mission of the Cardiac Safety Research Consortium is to advance regulatory science specifically related to pre-competitive cardiac safety issues through the collaborative means of a public-private partnership across interested stakeholders. The CSRC stands fully ready to encourage, contribute to, embrace and support elements of clinical science such as good scientific design, data analysis, interpretation and dissemination to the public domain within the construct of the resources and committee structure of the public-private partnership forum.